News

Takeda Pharma said that the once-daily prescription medication, available in two commonly used dosages of pioglitazone and metformin XR – 15 mg/1000 mg and 30 mg/1000 mg tablets,

The QL Care Analyzer will be tested utilising CardioGenics’ Troponin-I test, the first in a series of four cardiovascular tests to be offered for use with the QL

As part of the commercialisation agreement, Diamyd holds the right to commercialise the product in the Nordic states. GAD65 is currently being assessed in Phase 3 clinical studies

Dr Arella has more than 30 years of experience as a University professor, and director of a large Research Center for 5 years. Dr Arella also has experience

Incline is developing an investigational product candidate intended to provide patient-controlled analgesia for adult inpatients requiring opioids following surgery, called IONSYS (fentanyl iontophoretic transdermal system). IONSYS is a

Under the terms of the agreement, Saladax Biomedical and Bristol-Myers Squibb will collaborate globally on development and regulatory approvals. Saladax received exclusive global rights to commercialize the assays

Mead Johnson and Martek said that DHA and ARA are fatty acids important to infant development and growth. Clinical studies have demonstrated benefits for infants receiving DHA and

The clinical trial is expected to be held at the Hospital ‘la Timone’ in Marseilles, France. The aim of the clinical trial is to show safety and proof-of-concept

Hematide/peginesatide is Affymax’s investigational drug for the treatment of anemia in chronic renal failure patients. Affymax and Takeda said that the payments were triggered by the achievement of